The value of bone scintigraphy in the follow-up of vertebral osteoporosis
- PMID: 1790640
- DOI: 10.1007/BF02208694
The value of bone scintigraphy in the follow-up of vertebral osteoporosis
Abstract
In an open study, we have assessed the bone/soft tissue uptake index in recent osteoporotic vertebral collapse using scintigraphy. The evolution of these cases was followed-up at 6 months in 22 patients treated with 100 IU of salmon calcitonin plus 500 mg of elemental calcium/10 days per month and in 18 patients treated with 500 mg of elemental calcium only on a daily basis. There were no index differences between groups prior to treatment. At six months, the group treated with calcitonin plus calcium showed a significant decrease from 10.2 +/- 6.4 to 3.2 +/- 1.1 (p less than 0.001), while the calcium only group did not show any significant changes (12.1 +/- 6.6 vs 9.2 +/- 4.6), considering that there were significant differences between groups (p less than 0.001). On a mid-term basis, these results have shown the values of the bone/soft tissue index in the follow-up of osteoporotic vertebral collapse.
Similar articles
-
Calcitonin and calcium combined therapy in osteoporosis: effects on vertebra trabecular bone density.J Int Med Res. 1989 Jul-Aug;17(4):395-400. doi: 10.1177/030006058901700414. J Int Med Res. 1989. PMID: 2792558
-
Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study.Calcif Tissue Int. 1995 Mar;56(3):181-5. doi: 10.1007/BF00298606. Calcif Tissue Int. 1995. PMID: 7750020 Clinical Trial.
-
Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.Clin Rheumatol. 2005 Jun;24(3):232-8. doi: 10.1007/s10067-004-1004-6. Epub 2005 Jan 13. Clin Rheumatol. 2005. PMID: 15647969 Clinical Trial.
-
Calcitonin therapy in osteoporosis.Treat Endocrinol. 2004;3(2):117-32. doi: 10.2165/00024677-200403020-00006. Treat Endocrinol. 2004. PMID: 15743107 Review.
-
[Osteoporosis].Union Med Can. 1985 Oct;114(10):857-64. Union Med Can. 1985. PMID: 3909576 Review. French. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Medical